Loading
Everything OnCo dates to 1987: 30 entries, 14 landmarks, 7 journals founded, 4 papers and 2 companies founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
30 dated entries in OnCo fall in 1987: 14 landmarks, 7 journals founded, 4 papers, 2 companies founded, 1 approval, 1 law or regulation and 1 paper listed on a person's page.
Of those, 30 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Acute non-lymphocytic leukaemia in adults (combination); later hormone-refractory prostate cancer pain (with corticosteroids) and multiple sclerosis
The statutes, regulations, guidance and court rulings in the law index, dated to the year the instrument was made.
United States, regulation.
The publication year on key paper records.
Stamey TA, Yang N, Hay AR, et al. New England Journal of Medicine.
Tempero MA, Uchida E, Takasaki H, et al. Cancer Research.
Slamon DJ, Clark GM, Wong SG, et al. Science.
Williams SD, Birch R, Einhorn LH, et al. New England Journal of Medicine.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Atypical teratoid/rhabdoid tumour (ATRT). Rorke and colleagues recognise the rhabdoid tumour of the CNS.
Non-seminomatous germ cell tumour
Extragonadal germ cell tumour. Etoposide in place of vinblastine gave equal cure with less neurotoxicity in the Indiana and SECSG trials.
Testicular germ cell tumours. Etoposide substitutes vinblastine with better efficacy and less neurotoxicity.
Head and neck squamous cell carcinoma. VA Larynx study establishes organ preservation with chemoradiation.
Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)
Triple-negative breast cancer (TNBC). Slamon and colleagues, 189 tumours. With the oestrogen and progesterone receptor assays it completed the three tests whose absence defines tri...
Single-system Langerhans cell histiocytosis (bone, skin or one other organ)
Pancreatic ductal adenocarcinoma. Tempero and colleagues, 20 patients: a normal marker never rules the cancer out.
Neuroendocrine tumours
Prostate cancer. Stamey measured the antigen in 2,200 samples from 699 patients: it tracked tumour volume, fell to undetectable after prostatectomy with a half-life of 2.2 days, an...
HER2-positive breast cancer. Science paper identifying HER2/neu amplification in 25-30% of breast cancers.
Early HER2-positive breast cancer
Skin cancer (all types). 117 basal cell carcinomas marked in 2 mm increments before Mohs surgery showed that 4 mm clears more than 95 per cent of tumours under 2 cm; the 1992 compa...
The founded year on company records.
Lucas Heights, Sydney
Parsippany, NJ
The founded year on journal records.
Medical Journals Sweden AB (MJS Publishing)
Cold Spring Harbor Laboratory Press
Elsevier
International Institute of Anticancer Research (IIAR)
Springer Nature
Springer Nature (Nature Portfolio)
MJH Life Sciences
The selected publications each biography lists, which is a reading of that person rather than a reading of the year.
Science